RankingsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Stockholders' equity

ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】

Market cap
¥608.6B
P/E ratio
18.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 2025271,440+9.88%
Mar 31, 2024247,036+14.86%
Mar 31, 2023215,078+17.00%
Mar 31, 2022183,832+17.38%
Mar 31, 2021156,612+11.84%
Mar 31, 2020140,032+5.93%
Mar 31, 2019132,189+2.92%
Mar 31, 2018128,440+8.45%
Mar 31, 2017118,436+6.44%
Mar 31, 2016111,271+0.68%
Mar 31, 2015110,516+12.05%
Mar 31, 201498,627

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)